Business Description
Shaanxi Meibang Pharmaceutical Group Co Ltd
ISIN : CNE100005071
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 7.16 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 2.66 | |||||
Interest Coverage | 805.54 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.91 | |||||
Beneish M-Score | -3.64 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.5 | |||||
3-Year EBITDA Growth Rate | -14.4 | |||||
3-Year EPS without NRI Growth Rate | -28.2 | |||||
3-Year FCF Growth Rate | 96 | |||||
3-Year Book Growth Rate | 23 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 26.01 | |||||
9-Day RSI | 30.81 | |||||
14-Day RSI | 36.19 | |||||
6-1 Month Momentum % | 5.67 | |||||
12-1 Month Momentum % | -25.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.86 | |||||
Quick Ratio | 2.38 | |||||
Cash Ratio | 1.42 | |||||
Days Inventory | 170.89 | |||||
Days Sales Outstanding | 122.5 | |||||
Days Payable | 101.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.64 | |||||
Dividend Payout Ratio | 0.42 | |||||
Forward Dividend Yield % | 1.64 | |||||
5-Year Yield-on-Cost % | 1.56 | |||||
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | -0.51 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 30.14 | |||||
Operating Margin % | 3.67 | |||||
Net Margin % | 3.99 | |||||
FCF Margin % | 20.92 | |||||
ROE % | 2.7 | |||||
ROA % | 1.86 | |||||
ROIC % | 3.04 | |||||
ROC (Joel Greenblatt) % | 3.69 | |||||
ROCE % | 2.07 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 52.61 | |||||
PE Ratio without NRI | 33.99 | |||||
PS Ratio | 2.11 | |||||
PB Ratio | 1.44 | |||||
Price-to-Tangible-Book | 1.6 | |||||
Price-to-Free-Cash-Flow | 9.67 | |||||
Price-to-Operating-Cash-Flow | 4.55 | |||||
EV-to-EBIT | 42.05 | |||||
EV-to-EBITDA | 42.05 | |||||
EV-to-Revenue | 1.5 | |||||
EV-to-FCF | 7.54 | |||||
Price-to-Graham-Number | 1.56 | |||||
Price-to-Net-Current-Asset-Value | 3.76 | |||||
Earnings Yield (Greenblatt) % | 2.38 | |||||
FCF Yield % | 9.82 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Shaanxi Meibang Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 768.171 | ||
EPS (TTM) (Â¥) | 0.23 | ||
Beta | 1.12 | ||
Volatility % | 31.9 | ||
14-Day RSI | 36.19 | ||
14-Day ATR (Â¥) | 0.559953 | ||
20-Day SMA (Â¥) | 13.302 | ||
12-1 Month Momentum % | -25.82 | ||
52-Week Range (Â¥) | 9.73 - 19.24 | ||
Shares Outstanding (Mil) | 135.2 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Shaanxi Meibang Pharmaceutical Group Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Shaanxi Meibang Pharmaceutical Group Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Shaanxi Meibang Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Shaanxi Meibang Pharmaceutical Group Co Ltd(SHSE:605033)'s stock price today?
When is next earnings date of Shaanxi Meibang Pharmaceutical Group Co Ltd(SHSE:605033)?
Does Shaanxi Meibang Pharmaceutical Group Co Ltd(SHSE:605033) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |